BCPEM
GILD icon

Bain Capital Public Equity Management’s Gilead Sciences GILD Stock Holding History

Bain Capital Public Equity Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,050
Closed -$428K – 79
2017
Q4 		$428K Buy
+2,050
New +$156K 0.03% 73

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bain Capital Public Equity Management's GILD Position: Q2 2018 in Review

Bain Capital Public Equity Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 55,864 shares — an estimated $4.21M sold.

Bain Capital Public Equity Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $189M in Q2 2013. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Bain Capital Public Equity Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 55,864 Gilead Sciences shares in Q2 2018, an estimated $4.21M.
  • Bain Capital Public Equity Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Bain Capital Public Equity Management's Gilead Sciences position peaked at $189M in Q2 2013.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.